GLOW Blend 70mg

GLOW holds three peptides: GHK-Cu at 50 mg, BPC-157 at 10 mg, and TB-500 at 10 mg.

Check the mass distribution before you reconstitute. GHK-Cu accounts for 50 of the 70 mg because copper-tripeptide work typically runs at concentrations an order of magnitude above those used for the other two. A single reconstitution therefore gives three different concentrations from one vial: at 3.5 ml you have roughly 14.3 mg/ml GHK-Cu and 2.9 mg/ml of each repair peptide.

Each constituent brings a separate pathway. GHK-Cu, the copper-bound glycyl-histidyl-lysine tripeptide, is studied for extracellular matrix signalling, collagen gene expression and metalloproteinase regulation. BPC-157 is studied for angiogenesis. TB-500 is studied for actin binding and cell migration. Dermal research that touches matrix remodelling, vascular supply and cell motility at once would otherwise need three vials and three dilution series.

KLOW is the same combination plus KPV at 10 mg, for models that also need the α-MSH-derived inflammatory arm.

Supplied as a lyophilised powder at ≥99% purity by HPLC, with batch LC-MS identity confirmation and a certificate of analysis. Reconstitute with bacteriostatic water, store the sealed vial at -20°C, and keep reconstituted solution at 2-8°C. Copper complexes are light-sensitive, so keep the vial dark throughout.

For in-vitro laboratory research only. Not for human or veterinary use.